Work

Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate

Year: 2018

Type: article

Source: The American Journal of Medicine

DOI: 10.1016/j.amjmed.2018.07.008

Authors: Phillip H. Lam, Neha Gupta, Daniel J. Dooley, Steven Singh, Prakash Deedwania, Michael R. Zile, Deepak L. Bhatt, Charity J. Morgan, Bertram Pitt, Gregg C. Fonarow, Ali Ahmed

Institutions: Brigham and Women's Hospital, Veterans Health Administration, Washington DC VA Medical Center, Georgetown University, MedStar Heart & Vascular Institute, University of California, San Francisco, Medical University of South Carolina, Ralph H. Johnson VA Medical Center, Harvard University, University of Alabama at Birmingham, University of Michigan, University of California, Los Angeles, George Washington University

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Ironwood Pharmaceuticals, Incorporated, Amarin Corporation, Medicines Company, Eisai, National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: Neurohormonal Blockade and Outcomes in Diastolic Heart Failure, Heart failure, chronic kidney disease, and renin-angiotensin system inhibition

OpenAlex ID: W2887547688

FWCI: 3.208

Cites: 33

Cited by: 36

Related to: 10